Haverkate F - Search Results

1

Relationship between CRP and clinical course of unstable angina depends on assay method.

de Maat MP, Haverkate F, Kluft C. de Maat MP, et al. Among authors: haverkate f. Vascul Pharmacol. 2002 Aug;39(3):113-5. doi: 10.1016/s1537-1891(02)00296-3. Vascul Pharmacol. 2002. PMID: 12616976

2

Inflammatory status as a main determinant of outcome in patients with unstable angina, independent of coagulation activation and endothelial cell function.

Verheggen PW, de Maat MP, Cats VM, Haverkate F, Zwinderman AH, Kluft C, Bruschke AV. Verheggen PW, et al. Among authors: haverkate f. Eur Heart J. 1999 Apr;20(8):567-74. doi: 10.1053/euhj.1998.1312. Eur Heart J. 1999. PMID: 10337541 Clinical Trial.

3

Antibodies to Chlamydia pneumoniae and clinical course in patients with unstable angina pectoris.

de Maat MP, Ossewaarde JM, Verheggen PW, Kluft C, Cats VM, Haverkate F. de Maat MP, et al. Among authors: haverkate f. Atherosclerosis. 2000 Dec;153(2):499-504. doi: 10.1016/s0021-9150(00)00436-6. Atherosclerosis. 2000. PMID: 11164440

4

Long-term analytical performance of hemostasis field methods as assessed by evaluation of the results of an external quality assessment program for antithrombin.

Meijer P, de Maat MP, Kluft C, Haverkate F, van Houwelingen HC. Meijer P, et al. Among authors: haverkate f. Clin Chem. 2002 Jul;48(7):1011-5. Clin Chem. 2002. PMID: 12089168

5

The long-term within- and between-laboratory variability for assay of antithrombin, and proteins C and S: results derived from the external quality assessment program for thrombophilia screening of the ECAT Foundation.

Meijer P, Kluft C, Haverkate F, De Maat MP. Meijer P, et al. Among authors: haverkate f. J Thromb Haemost. 2003 Apr;1(4):748-53. doi: 10.1046/j.1538-7836.2003.00141.x. J Thromb Haemost. 2003. PMID: 12871411 Free article.

6

A model for the harmonisation of test results of different quantitative D-dimer methods.

Meijer P, Haverkate F, Kluft C, de Moerloose P, Verbruggen B, Spannagl M. Meijer P, et al. Among authors: haverkate f. Thromb Haemost. 2006 Mar;95(3):567-72. doi: 10.1160/TH05-01-0042. Thromb Haemost. 2006. PMID: 16525589 Free article.

7

Elevated plasma fibrinogen: cause or consequence of cardiovascular disease?

van der Bom JG, de Maat MP, Bots ML, Haverkate F, de Jong PT, Hofman A, Kluft C, Grobbee DE. van der Bom JG, et al. Among authors: haverkate f. Arterioscler Thromb Vasc Biol. 1998 Apr;18(4):621-5. doi: 10.1161/01.atv.18.4.621. Arterioscler Thromb Vasc Biol. 1998. PMID: 9555868

8

Inactivation of single-chain urokinase-type plasminogen activator by thrombin in human subjects.

Braat EA, Levi M, Bos R, Haverkate F, Lassen MR, de Maat MP, Rijken DC. Braat EA, et al. Among authors: haverkate f. J Lab Clin Med. 1999 Aug;134(2):161-7. doi: 10.1016/s0022-2143(99)90121-x. J Lab Clin Med. 1999. PMID: 10444030 Clinical Trial.

9

Performance of semiquantitative and quantitative D-dimer assays in the ECAT external quality assessment program.

de Maat MP, Meijer P, Nieuwenhuizen W, Haverkate F, Kluft C. de Maat MP, et al. Among authors: haverkate f. Semin Thromb Hemost. 2000;26(6):625-30. doi: 10.1055/s-2000-13218. Semin Thromb Hemost. 2000. PMID: 11140799 Review.

10

Performance goals for the laboratory testing of antithrombin, protein C and protein S.

Meijer P, Haverkate F, Kluft C. Meijer P, et al. Among authors: haverkate f. Thromb Haemost. 2006 Nov;96(5):584-9. Thromb Haemost. 2006. PMID: 17080214

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

88 results

Search Page

Filters